免疫能力强的患者患有微型白杆菌诱导的假体膜感染性内心炎:来自印度的病例报告
Ritvik Sajan1, Sreekrishnan Trikkur Parasuraman2, Akhil Arun3
1Department of Pharmacy Practice Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, Kerala, India.
Therapeutic advances in infectious disease
|December 22, 2025
概括
通常是污染物的微球菌 (Micrococcus luteus) 在健康人群中越来越多地引起内心炎等感染. 这一案例凸显了这种细菌潜在的进化变化,引发了新的健康问题.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 心脏病学 心脏病学
背景情况:
- 微球菌 (Micrococcus luteus,M. luteus) 是一种格拉姆阳性细菌,通常被发现是皮肤污染物.
- 虽然M. luteus感染通常发生在免疫功能低下的人群中,但最近的报告表明,免疫能力较强的人群的感染潜力增加.
- 假体内心炎是一种严重的疾病,通常与更致命的病原体有关.
研究的目的:
- 报告一个罕见的假体膜感染性内心炎病例,由M. luteus引起,在一个免疫能力强的患者中.
- 讨论M. luteus可能进化增加病原性的影响.
- 在特定的临床场景中提高人们对M. luteus作为潜在的病原体的认识.
主要方法:
- 一个68岁的女性出现发烧和部疼痛的病例报告.
- 血培养结果对M. luteus呈阳性,患者有假体门置换病史.
- 用静脉注射万科米辛治疗和感染标志物的监测.
主要成果:
- 该患者被诊断患有由M. luteus引起的假感染性内心炎.
- 重复的血液培养证实了M. luteus的存在,排除了污染.
- 患者成功完成了为期8周的万科米辛治疗,完全消除了症状和消除了感染标志物.
结论:
- 这一案例证明了M. luteus假感染性内心炎在免疫能力强的个体中新出现的情况.
- 这些发现表明,M. luteus.的病原性可能发生进化转变.
- 需要进一步的研究,以了解M. luteus.的不断变化的传染能力.
相关概念视频
Endocarditis I: Introduction
362
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
362
Endocarditis II: Clinical Features of Infective Endocarditis
371
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
371
Endocarditis III: Medical Management
197
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
197
Endocarditis IV: Nursing Management
297
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
297
Mitral Stenosis III: Medical Management
220
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
220
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
5.3K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
5.3K


